DAD. Kent Arrell

D. Kent Arrell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


D. Kent Arrell has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Proteomic Network Systems Analysis

    by D. Kent Arrell, Andre Terzic


  • Open Access

    Delineating RBM20 regulation of alternative splicing in dilated cardiomyopathy.

    by D. Kent Arrell, Mohsin A.F. Khan, Yolan J. Reckman, Simona Aufiero, Maarten M.G. van Den Hoogenhof, Ingeborg van der Made, Abdelaziz Beqqali, Dave R. Koolbergen, Torsten B. Rasmussen, Jolanda van der Velden, et al.


  • Open Access

    Metabolome and metaboproteome remodeling in nuclear reprogramming

    by Clifford Dl Folmes, D Kent Arrell, Jelena Zlatkovic-Lindor, Almudena Martinez-Fernandez, Carmen Perez-Terzic, Timothy J Nelson, Andre Terzic

    Nuclear reprogramming resets differentiated tissue to generate induced pluripotent stem (iPS) cells. While genomic attributes underlying reacquisition of the embryonic-like state have been delineated, less is known regarding the metabolic dynamics underscoring induction of pluripotency. Metabolomic profiling of fibroblasts vs. iPS cells demonstrated nuclear reprogramming-associated induction of glycolysis, realized through augmented utilization of glucose and accumulation of lactate. Real-time assessment unmasked downregulated mitochondrial reserve capacity and ATP turnover correlating with pluripotent induction. Reduction in oxygen consumption and acceleration of extracellular acidification rates represent high-throughput markers of the transition from oxidative to glycolytic metabolism, characterizing stemness acquisition. The bioenergetic transition was supported by proteome remodeling, whereby 441 proteins were altered between fibroblasts and derived iPS cells. Systems analysis revealed overrepresented canonical pathways and interactome-associated biological processes predicting differential metabolic behavior in response to reprogramming stimuli, including upregulation of glycolysis, purine, arginine, proline, ribonucleoside and ribonucleotide metabolism, and biopolymer and macromolecular catabolism, with concomitant downregulation of oxidative phosphorylation, phosphate metabolism regulation, and precursor biosynthesis processes, prioritizing the impact of energy metabolism within the hierarchy of nuclear reprogramming. Thus, metabolome and metaboproteome remodeling is integral for induction of pluripotency, expanding on the genetic and epigenetic requirements for cell fate manipulation.


  • Interpreting Networks in Systems Biology

    by D K Arrell, A Terzic

    Implementation of network systems biology principles offers unparalleled opportunity to synthesize and integrate inherently complex high‐throughput data for meaningful interpretation. Nonstochastic network templates constructed from extant knowledge facilitate large data set prioritization and prognostication, identifying context‐dependent candidates for follow‐up functional validation and interpretation. In conjunction, enrichment and representation assessment refines comprehension of network‐associated molecular functions and biological processes. Together, exploiting intrinsic network properties provides a value‐added decision‐support instrument for data deconvolution in systems biomedicine.


  • Systems Proteomics for Translational Network Medicine

    by D. Kent Arrell, Andre Terzic

    Proteomics encompasses diverse methods by which to study proteins, their abundance, structure, posttranslational modifications, and physical or functional interacting partners to map the proteome, the protein complement of a genome. Although such methods can be applied to individual proteins, proteomics facilitates large-scale analysis of complete proteomes or targeted subproteomes (Table 1). Moreover, proteomics enables comparisons between distinct conditions/states, from defined biological sources, across discrete timelines. In general, a proteomic cartography pipeline involves sample acquisition, followed by protein isolation, separation, resolution, and identification (Figure). Along this continuum, each successive module harbors a multistep process, whereby proteomic methodologies can be implemented. Figure. Network systems proteomic pipeline. Strategy extending proteomic profiling from mapping and quantification of protein identities to ontological categorization, pathway analysis and network generation for inclusive systems interpretation. View this table: Table 1. Systems Proteomics Lexicon Once proteins are isolated from the source of interest, 2 major separation strategies have evolved to address proteome complexity.1,2 Traditional gel-based approaches, particularly 2-dimensional gel electrophoresis involving isoelectric focusing followed orthogonally by sodium dodecyl sulfate - polyacrylamide gel electrophoresis, were the earliest methods adopted for protein separation and resolution, comparative assessment of relative abundance, and initial reduction of protein complexity before mass spectrometry (MS). Although 2-dimensional gel electrophoresis remains common, the advent of quantitative MS techniques has led to increased application of various gel-based and gel-free alternatives, whereby protein or peptide complexity is addressed by separation and resolution before or in conjunction with MS, whereas quantification is subsequently measured from MS precursor or fragment ion spectra. Choice of separation strategy is influenced by study objectives and resources, often guided by advantages and limitations to each approach. Quantitative MS methods tend to be less time- and labor-intensive while offering greater potential throughput and data acquisition, yet in instances where 2-dimensional gel electrophoresis approaches are applied in parallel, use of …


  • Network Systems Biology for Drug Discovery

    by D K Arrell, A Terzic

    Systems biology provides a platform for integrating multiple components and interactions underlying cell, organ, and organism processes in health and disease. Beyond traditional approaches focused on individual molecules or pathways, bioinformatic network analysis of high-throughput data sets offers an opportunity for integration of biological complexity and multilevel connectivity. Emerging applications in rational drug discovery range from targeting and modeling disease-corrupted networks to screening chemical or ligand libraries to identification/validation of drug-target interactions for improved efficacy and safety.